Evidence Synthesis Challenges Universal Antibiotic Exposure Rules for
An evidence synthesis evaluating how antibiotic prescribing relates to the emergence of resistant Gram-negative bacteria concludes that published studies can’t be combined to set universal rules for treatment duration or exposure thresholds. Researchers reviewing eighteen identifiable clinical reports found that clinical endpoints, exposure measurements, and baseline microbiological assessment vary too widely to compute a meaningful pooled risk estimate. Rather than supporting blanket prescribing guidance, the review suggests resistance dynamics are highly dependent on the specific drug regimen, anatomical site, and patient population. It also notes that common prescribing metrics are not directly convertible, and that detecting a resistant pathogen after antibiotics doesn’t always mean newly acquired resistance. The synthesis rechecked randomized trials, exposure cohorts, and case-control studies, uncovering discrepancies between original reports and legacy secondary extractions.






